These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1561667)

  • 1. Coagulation assays for the lupus anticoagulant: review and critique of current methodology.
    Triplett DA
    Stroke; 1992 Feb; 23(2 Suppl):I11-4. PubMed ID: 1561667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for the lupus anticoagulant.
    Triplett DA
    Ric Clin Lab; 1989; 19(4):379-89. PubMed ID: 2517352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar V
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL
    Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.
    Thom J; Ivey L; Gilmore G; Eikelboom JW
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):353-7. PubMed ID: 15166923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants.
    Moore GW; Savidge GF
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):279-82. PubMed ID: 15060428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus Anticoagulant Testing: Dilute Prothrombin Time (dPT).
    Moore GW
    Methods Mol Biol; 2023; 2663():275-288. PubMed ID: 37204717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the reagent "IL Test LAC Screen/IL Test LAC Confirm" for the biological diagnosis of circulating lupus anticoagulants].
    Magdelaine A; Verdy E
    Ann Biol Clin (Paris); 1996; 54(7):293-6. PubMed ID: 8952726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants.
    Moore GW; Smith MP; Savidge GF
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):307-12. PubMed ID: 12695757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
    Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of recently described tests for detection of the lupus anticoagulant.
    Forastiero RR; Cerrato GS; Carreras LO
    Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory characteristics of isolated lupus anticoagulants.
    Mattia E; Tonello M; Del Ross T; Zerbinati P; Campello E; Simioni P; Ruffatti A
    Thromb Res; 2018 May; 165():51-53. PubMed ID: 29567587
    [No Abstract]   [Full Text] [Related]  

  • 20. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time.
    Moore GW; Savidge GF; Smith MP
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):767-74. PubMed ID: 11132656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.